Rani Therapeutics (RANI) Institutional Ownership → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free RANI Stock Alerts $7.15 -0.31 (-4.16%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)CurrentInstitutional OwnershipPercentage30.19%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$297.08KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$431.60K Get RANI Insider Trade Alerts Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RANI Institutional Buying and Selling by Quarter Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> Rani Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024Alpha Square Group S LLC58,946$196K0.2%-32.2%0.118% 8/10/2023King Luther Capital Management Corp56,129$231K0.0%N/A0.113% 8/4/2023 Choreo LLC19,813$82K0.0%-20.2%0.040% 5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026% 5/11/2023 Alphabet Inc.448,492$2.31M0.1%-12.1%0.908% 2/8/2023Prime Capital Investment Advisors LLC33,502$198K0.0%N/A0.068% 11/18/2022TPB Wealth Advisors48,129$461K0.2%-33.0%0.098% 11/16/2022 Alphabet Inc.714,471$6.85M0.3%N/A1.453% 11/3/2022Motco48,129$461K0.0%N/A0.098% 10/28/2022Lafayette Investments Inc.19,893$191K0.1%N/A0.040% 10/17/2022Canton Hathaway LLC16,200$155K0.1%+88.4%0.033% 10/14/2022 Iowa State Bank18,862$181K0.1%N/A0.038% 8/8/2022Islay Capital Management LLC9,611$99K0.1%N/A0.020% 8/8/2022Crossvault Capital Management LLC14,285$148K0.1%N/A0.029% 7/29/2022Aspireon Wealth Advisors71,811$742K0.3%N/A0.146% 7/20/2022Canton Hathaway LLC8,600$89K0.0%N/A0.017% 6/15/2022Lasry Marc62,828$848K0.4%N/A0.128% 5/17/2022Lasry Marc62,828$848K0.4%N/A0.128% 5/13/2022United Services Automobile Association481,300$6.50M0.1%N/A0.979% 2/3/2022Advisor Group Holdings Inc.21,072$344K0.0%N/A0.043% 1/6/2022Canton Hathaway LLC5,000$82K0.0%-50.0%0.010% 11/16/2021Squarepoint Ops LLC50,000$891K0.0%N/A0.102% 11/15/2021 Caas Capital Management LP75,000$1.34M0.0%N/A0.153% 11/10/2021Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124% (Data available from 1/1/2016 forward) RANI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RANI shares? During the previous two years, 16 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were United Services Automobile Association ($6.50M), Alphabet Inc. ($2.31M), Lasry Marc ($848K), Aspireon Wealth Advisors ($742K), TPB Wealth Advisors ($461K), Motco ($461K), and King Luther Capital Management Corp ($231K).Learn more on RANI's institutional investors. What percentage of Rani Therapeutics stock is owned by institutional investors? 30.19% of Rani Therapeutics stock is owned by institutional investors. Learn more on RANI's institutional investor holdings. Which institutional investors have been buying Rani Therapeutics stock? Of the 13 institutional investors that purchased Rani Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alphabet Inc. ($714.47K), United Services Automobile Association ($481.30K), Lasry Marc ($125.66K), Aspireon Wealth Advisors ($71.81K), King Luther Capital Management Corp ($56.13K), Motco ($48.13K), and Prime Capital Investment Advisors LLC ($33.50K). How much institutional buying is happening at Rani Therapeutics? Institutional investors have bought a total of 1,622,606 shares in the last 24 months. This purchase volume represents approximately $17.52M in transactions. Which Rani Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Rani Therapeutics stock in the last 24 months: Alphabet Inc. ($61.64K), Alpha Square Group S LLC ($28K), TPB Wealth Advisors ($23.68K), and Choreo LLC ($5K). How much institutional selling is happening at Rani Therapeutics? Institutional investors have sold a total of 118,318 shares in the last 24 months. This volume of shares sold represents approximately $658.48K in transactions. Related Companies: URGN Major Shareholders NLTX Major Shareholders SBTX Major Shareholders TERN Major Shareholders PGEN Major Shareholders AVIR Major Shareholders ORGO Major Shareholders NKTX Major Shareholders ATAI Major Shareholders ERAS Major Shareholders This page (NASDAQ:RANI) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.